15610 Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control 

Special Emphasis Panel (SEP): Initial 

Review 

The meeting announced below 

concerns Cooperative Research 

Agreements to the World Trade Center 

Health Program (U01) PAR 12–126, 

initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 

8:00 a.m.–5:00 p.m., April 14, 2015 

(Closed) 

8:00 a.m.–12:00 p.m., April 15, 2015 

(Closed) 

Place: Atlanta Marriott Century 

Center, 2000 Century Boulevard NE., 

Atlanta, Georgia 30345, Telephone: 

(404) 325–0000. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Cooperative Research Agreements 

Related to the World Trade Center 

Health Program (U01) PAR 12–126.’’ 

Contact Person for More Information: 

Nina Turner, Ph.D., Scientific Review 

Officer, CDC/NIOSH, 1095 Willowdale 

Road, Mailstop G905, Morgantown, 

West Virginia 26505, Telephone: (304) 

285–5975. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–06650 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting for the initial 

review of applications in response to 

Funding Opportunity Announcements 

(FOA) GH11–002, Conducting Public 

Health Research in Thailand by the 

Ministry of Public Health (MOPH); FOA 

GH12–004M, Conducting Public Health 

Research in South Africa by the 

National Health Laboratory Service 

(NHLS); FOA GH12–005, Conducting 

Public Health Research in China; and 

FOA GH14–002, Addressing Emerging 

Infectious Diseases in Bangladesh. 

Time and Date: 8:30 a.m.–1:00 p.m., 

EST, April 15, 2015 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters for Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

FOA GH11–002, Conducting Public 

Health Research in Thailand by the 

Ministry of Public Health (MOPH); FOA 

GH12–004, Conducting Public Health 

Research in South Africa by the 

National Health Laboratory Service 

(NHLS); FOA GH12–005, Conducting 

Public Health Research in China; and 

FOA GH14–002, Addressing Emerging 

Infectious Diseases in Bangladesh. 

Contact Person for More Information: 

Hylan Shoob, Scientific Review Officer, 

Center for Global Health (CGH) Science 

Office, CGH, CDC, 1600 Clifton Road 

NE., Mailstop D–69, Atlanta, Georgia 

30033, Telephone: (404) 639–4796. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–06653 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel 

Pathobiology of Asthma. 

Date: April 14, 2015. 

Time: 1:30 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Room 7180, Bethesda, MD 

20817, (Telephone Conference Call). 

Contact Person: Tony L Creazzo, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7180, Bethesda, MD 20892–7924, 301–435– 

0725 creazzotl@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: March 18, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06594 Filed 3–23–15; 8:45 am] 

BILLING CODE 4140–01–P 

mstockstill on DSK4VPTVN1PROD with NOTICES